BeOne Medicines Ltd. American Depositary Shares

BeOne Medicines Ltd. American Depositary Shares is the U.S.-traded ADR of BeOne Medicines Ltd., a global oncology company based in Switzerland. The business focuses on discovering and developing treatments for cancer, with activity spanning hematology and solid tumor medicines, as well as broader oncology research and commercialization efforts. Its portfolio includes prescription therapies and clinical-stage drug candidates designed to address a range of cancer types across major markets in the United States, Europe, China, and other international regions. Through its American Depositary Shares, BeOne Medicines provides U.S. investors with access to the company’s ordinary shares in a form that is commonly used for foreign issuers in U.S. markets. The asset reflects a biotechnology and pharmaceutical platform centered on oncology innovation, with operations supported by global development, regulatory, and commercial capabilities.